Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -175,278 | -124,752 | -201,303 | -180,973 | -198,438 |
| Depreciation Amortization | 139,185 | 86,862 | 153,685 | 94,130 | 49,474 |
| Income taxes - deferred | -18,209 | -9,884 | -9,439 | -9,111 | -14,993 |
| Accounts receivable | -164,578 | -165,326 | 100,012 | -63,883 | -49,034 |
| Other Working Capital | -166,935 | -155,498 | -894 | -148,771 | -119,522 |
| Other Operating Activity | 298,499 | 260,188 | 208,169 | 299,187 | 260,963 |
| Operating Cash Flow | $-87,316 | $-108,410 | $250,230 | $-9,421 | $-71,550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29,629 | -17,988 | -57,744 | -63,065 | -36,600 |
| Net Acquisitions | 34,834 | -3,478 | -324,634 | -324,634 | -321,324 |
| Purchase Sale Intangibles | -50,000 | N/A | -14,000 | -14,000 | -3,000 |
| Other Investing Activity | -50,000 | 0 | -14,000 | -14,000 | -3,000 |
| Investing Cash Flow | $-44,795 | $-21,466 | $-396,378 | $-401,699 | $-360,924 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,325,383 | 1,350,383 | 1,325,383 |
| Debt Repayment | -14,366 | -7,369 | -617,294 | -610,482 | -603,672 |
| Common Stock Issued | 1,385 | 1,010 | 3,797 | 3,162 | 1,977 |
| Common Stock Repurchased | N/A | -2,011 | N/A | N/A | N/A |
| Other Financing Activity | -17,958 | -13,494 | -424,211 | -236,468 | -299,693 |
| Financing Cash Flow | $-30,939 | $-21,864 | $287,675 | $506,595 | $423,995 |
| Exchange Rate Effect | 1,293 | -296 | -670 | -1,204 | -853 |
| Beginning Cash Position | 218,779 | 218,779 | 77,922 | 77,922 | 77,922 |
| End Cash Position | 57,022 | 66,743 | 218,779 | 172,193 | 68,590 |
| Net Cash Flow | $-161,757 | $-152,036 | $140,857 | $94,271 | $-9,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,316 | -108,410 | 250,230 | -9,421 | -71,550 |
| Capital Expenditure | -29,629 | -17,988 | -83,088 | -63,065 | -36,600 |
| Free Cash Flow | -116,945 | -126,398 | 167,142 | -72,486 | -108,150 |